Fig. 3: Cumulative minimum inhibitory concentration (MIC) distributions for Debio 1453 and comparator antibiotics for 100 clinical Neisseria gonorrhoeae isolates collected from Sweden in 2023. | Nature Communications

Fig. 3: Cumulative minimum inhibitory concentration (MIC) distributions for Debio 1453 and comparator antibiotics for 100 clinical Neisseria gonorrhoeae isolates collected from Sweden in 2023.

From: The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo

Fig. 3: Cumulative minimum inhibitory concentration (MIC) distributions for Debio 1453 and comparator antibiotics for 100 clinical Neisseria gonorrhoeae isolates collected from Sweden in 2023.

Relevant EUCAST resistance breakpoints or epidemiological cutoff (ECOFF) for N. gonorrhoeae: ceftriaxone, >0.125 µg/mL; azithromycin, 1 µg/mL (ECOFF); spectinomycin, >64 µg/mL; tetracycline, >0.5 µg/mL; and ciprofloxacin, >0.06 µg/mL. The dotted line indicates 90% of cumulative isolates (MIC90). Source data are provided as a Source Data file.

Back to article page